209 related articles for article (PubMed ID: 31782984)
1. High pretreatment plasma Epstein-Barr virus (EBV) DNA level is a poor prognostic marker in HIV-associated, EBV-negative diffuse large B-cell lymphoma in Malawi.
Montgomery ND; Randall C; Painschab M; Seguin R; Kaimila B; Kasonkanji E; Zuze T; Krysiak R; Sanders MK; Elliott A; Miller MB; Kampani C; Chimzimu F; Mulenga M; Damania B; Tomoka T; Fedoriw Y; Dittmer DP; Gopal S
Cancer Med; 2020 Jan; 9(2):552-561. PubMed ID: 31782984
[TBL] [Abstract][Full Text] [Related]
2. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
Okamoto A; Yanada M; Miura H; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
Cancer Sci; 2015 Nov; 106(11):1576-81. PubMed ID: 26353084
[TBL] [Abstract][Full Text] [Related]
4. Reappraisal of the prognostic value of Epstein-Barr virus status in monomorphic post-transplantation lymphoproliferative disorders-diffuse large B-cell lymphoma.
Kim JH; Cho H; Sung H; Jung AR; Lee YS; Lee SW; Ryu JS; Chae EJ; Kim KW; Huh J; Park CS; Yoon DH; Suh C
Sci Rep; 2021 Feb; 11(1):2880. PubMed ID: 33536508
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma.
Bossolasco S; Cinque P; Ponzoni M; Vigano MG; Lazzarin A; Linde A; Falk KI
J Neurovirol; 2002 Oct; 8(5):432-8. PubMed ID: 12402169
[TBL] [Abstract][Full Text] [Related]
7. [The prognostic significance of plasma Epstein-Barr virus DNA in patients with diffuse large B cell lymphoma].
An N; Xie YP; Xu Y; Shi PF; Qian SX
Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):839-841. PubMed ID: 29136714
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal and cross-sectional study ofEpstein-Barr virus DNA load: a possible predictor of AIDS-related lymphoma in HIV-infected patients.
Hijlkema SH; van Kampen JJA; Voermans JJC; den Oudsten MYE; Doorduijn J; van Lugtenburg PJ; van de Vijver DAMC; van der Ende ME
Infect Dis (Lond); 2018; 50(11-12):847-852. PubMed ID: 30317893
[TBL] [Abstract][Full Text] [Related]
9. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
[TBL] [Abstract][Full Text] [Related]
10. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'.
Uner A; Akyurek N; Saglam A; Abdullazade S; Uzum N; Onder S; Barista I; Benekli M
APMIS; 2011 Apr; 119(4-5):309-16. PubMed ID: 21492232
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Semanova T; Prevot S; Costagliola D; Morand P; Besson C
AIDS; 2019 May; 33(6):993-1000. PubMed ID: 30946153
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B-cell lymphoma patients.
Okamoto A; Yanada M; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
Hematol Oncol; 2017 Mar; 35(1):87-93. PubMed ID: 26177728
[TBL] [Abstract][Full Text] [Related]
14. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma.
Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S
Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Hong JY; Ryu KJ; Park C; Hong M; Ko YH; Kim WS; Kim SJ
Oncotarget; 2017 Feb; 8(8):13782-13791. PubMed ID: 28099151
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
[TBL] [Abstract][Full Text] [Related]
17. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?
Monabati A; Vahedi A; Safaei A; Noori S; Mokhtari M; Vahedi L; Zamani M
Asian Pac J Cancer Prev; 2016; 17(4):2285-9. PubMed ID: 27221931
[TBL] [Abstract][Full Text] [Related]
19. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH
J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237
[TBL] [Abstract][Full Text] [Related]
20. Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus-related Lymphomas.
Muncunill J; Baptista MJ; Hernandez-Rodríguez Á; Dalmau J; Garcia O; Tapia G; Moreno M; Sancho JM; Martínez-Picado J; Feliu E; Mate JL; Ribera JM; Navarro JT
Clin Infect Dis; 2019 Feb; 68(5):834-843. PubMed ID: 29982484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]